Source: ERS Course 2019 - Masterclass in airways disease 2019
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Mario Cazzola (Italy). Alfa 1 antitrypsin deficit: only COPD or asthma as well?. ERS Course 2019 - Masterclass in airways disease 2019

Member's Comments

No comment yet.

Related content which might interest you: Patterns of exacerbations in alpha 1 antitrypsin deficiency (AATD) Source: International Congress 2015 – Connective tissue disorders Year: 2015 Alpha 1 antitrypsin (A1AT) deficiency in children with asthma in Brazil Source: Eur Respir J 2003; 22: Suppl. 45, 499s Year: 2003 Alpha-1 antitrypsin deficiency in COPD patients: Time to count it in! Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020 Alpha-1 antitrypsin deficiency in patients with COPD/emphysema, bronchiectasis and asthma Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases Year: 2020 Predicting clinical course of alpha 1 anti-trypsin deficiency (AATD) using GOLD 2011 classification Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Investigating change in the COPD assessment test (CAT) within α-1 antitrypsin deficiency (A1ATD) Source: Annual Congress 2011 - Phenotyping and monitoring of airway diseases Year: 2011 Bronchiectasis but not emphysema is more prevalent in non-PiZ alpha-1 antitrypsin deficiency (AATD) COPD than in usual COPD Source: International Congress 2014 – Genetics and environmental factors underlying asthma and COPD Year: 2014 Prevalence of alpha-1 antitrypsin deficiency (AATD) and frequencies of alleles PI*S and PI*Z in patients with COPD in Brazil Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population Year: 2013 The effect of posture on ventilation using SLP in healthy subject and patients with Alpha 1 anti-trypsin deficiency (A1AT) Source: International Congress 2014 – Respiratory function: quality and new technologies Year: 2014 Evaluation of protease-antiprotease imbalance in moderate COPD without antitrypsin deficiency Source: International Congress 2015 – Modulating the immune system in COPD and asthma Year: 2015 Reduction in incidence of exacerbations in patients with alpha 1 antitrypsin deficiency (A1ATD) treated with concentrates of alpha 1 antitrypsin (A1AT): REXA study Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 Difficult-to-treat asthma: how serious is the problem and what are the issues? Source: Eur Respir Mon 2011; 51: 1-15 Year: 2011 The national alpha-1 antitrypsin deficiency registry in Poland Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects Year: 2015 Pulmonary rehabilitation (PR) in patients with COPD due to alpha-1 antitrypsin deficiency (AATD): 15 years experience at the Maugeri Institute Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation Year: 2013 Relationship between atopy, asthma and alpha-1 antitrypsin deficiency Source: International Congress 2019 – Clinical aspects of airway diseases Year: 2019 Clinical features of alpha one antitrypsin deficiency in COPD Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012 Low vitamin D level and adult-onset bronchial asthma: Is there a link? Source: International Congress 2015 – Co-existing diseases and asthma Year: 2015 Ventilation heterogeneity reversibility: asthma, COPD or ACOS? Source: International Congress 2017 – Novel imaging findings characterising various lung diseases and their prognoses Year: 2017